These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Local suppression of T cell responses by arginase-induced L-arginine depletion in nonhealing leishmaniasis. Modolell M; Choi BS; Ryan RO; Hancock M; Titus RG; Abebe T; Hailu A; Müller I; Rogers ME; Bangham CR; Munder M; Kropf P PLoS Negl Trop Dis; 2009 Jul; 3(7):e480. PubMed ID: 19597544 [TBL] [Abstract][Full Text] [Related]
11. An effect of parasite-encoded arginase on the outcome of murine cutaneous leishmaniasis. Gaur U; Roberts SC; Dalvi RP; Corraliza I; Ullman B; Wilson ME J Immunol; 2007 Dec; 179(12):8446-53. PubMed ID: 18056391 [TBL] [Abstract][Full Text] [Related]
12. Progressive visceral leishmaniasis is driven by dominant parasite-induced STAT6 activation and STAT6-dependent host arginase 1 expression. Osorio EY; Zhao W; Espitia C; Saldarriaga O; Hawel L; Byus CV; Travi BL; Melby PC PLoS Pathog; 2012 Jan; 8(1):e1002417. PubMed ID: 22275864 [TBL] [Abstract][Full Text] [Related]
13. Antileishmanial activity of Urtica dioica extract against zoonotic cutaneous leishmaniasis. Badirzadeh A; Heidari-Kharaji M; Fallah-Omrani V; Dabiri H; Araghi A; Salimi Chirani A PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007843. PubMed ID: 31929528 [TBL] [Abstract][Full Text] [Related]
14. L-arginine metabolism and its impact on host immunity against Leishmania infection. Wanasen N; Soong L Immunol Res; 2008; 41(1):15-25. PubMed ID: 18040886 [TBL] [Abstract][Full Text] [Related]
15. The inhibition of arginase by N(omega)-hydroxy-l-arginine controls the growth of Leishmania inside macrophages. Iniesta V; Gómez-Nieto LC; Corraliza I J Exp Med; 2001 Mar; 193(6):777-84. PubMed ID: 11257143 [TBL] [Abstract][Full Text] [Related]
16. Growth factor and Th2 cytokine signaling pathways converge at STAT6 to promote arginase expression in progressive experimental visceral leishmaniasis. Osorio EY; Travi BL; da Cruz AM; Saldarriaga OA; Medina AA; Melby PC PLoS Pathog; 2014 Jun; 10(6):e1004165. PubMed ID: 24967908 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of Leishmanization Using Keshavarzian N; Noroozbeygi M; Haji Molla Hoseini M; Yeganeh F Front Immunol; 2020; 11():1725. PubMed ID: 33193290 [No Abstract] [Full Text] [Related]
18. Metabolomic Profile of BALB/c Macrophages Infected with Muxel SM; Mamani-Huanca M; Aoki JI; Zampieri RA; Floeter-Winter LM; López-Gonzálvez Á; Barbas C Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835767 [TBL] [Abstract][Full Text] [Related]
19. Investigations on the effects of anti-Leishmania major serum on the progression of Leishmania infantum infection in vivo and in vitro - implications of heterologous exposure to Leishmania spp. McNolty A; Anderson H; Stryker GA; Dondji B Parasitol Res; 2021 May; 120(5):1771-1780. PubMed ID: 33792813 [TBL] [Abstract][Full Text] [Related]